Filing Details

Accession Number:
0001144204-19-012829
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-07 20:52:26
Reporting Period:
2019-03-05
Accepted Time:
2019-03-07 20:52:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
910329 Medifast Inc MED Miscellaneous Food Preparations & Kindred Products (2090) 133714405
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207400 C Michael Macdonald C/O Medifast, Inc.,
100 International Drive
Baltimore MD 21202
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-03-05 6,607 $130.38 5,793 No 4 S Indirect Michael C. MacDonald Charitable Remainder Unitrust
Common Stock Disposition 2019-03-05 2,410 $131.46 3,383 No 4 S Indirect Michael C. MacDonald Charitable Remainder Unitrust
Common Stock Disposition 2019-03-05 2,883 $132.58 500 No 4 S Indirect Michael C. MacDonald Charitable Remainder Unitrust
Common Stock Disposition 2019-03-05 500 $133.34 0 No 4 S Indirect Michael C. MacDonald Charitable Remainder Unitrust
Common Stock Disposition 2019-03-05 3,654 $130.39 298,842 No 4 S Direct
Common Stock Disposition 2019-03-05 1,200 $131.44 297,642 No 4 S Direct
Common Stock Disposition 2019-03-05 1,371 $132.56 296,271 No 4 S Direct
Common Stock Disposition 2019-03-05 200 $133.30 296,071 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Michael C. MacDonald Charitable Remainder Unitrust
No 4 S Indirect Michael C. MacDonald Charitable Remainder Unitrust
No 4 S Indirect Michael C. MacDonald Charitable Remainder Unitrust
No 4 S Indirect Michael C. MacDonald Charitable Remainder Unitrust
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
  2. The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein.
  3. The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.02 to $131.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
  4. The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.02 to $132.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
  5. The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.03 to $133.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
  6. The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.005 to $130.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
  7. The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.00 to $131.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
  8. The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.02 to $132.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
  9. The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.02 to $133.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.